← Leaderboards
Micah A. Luftig
Duke University
$19,856,384
Attributed
$20,303,623
Total exposure
10
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.8M · FY2011–25$5M$3.8M$2.5M$1.3M$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$20,303,623 · 10
By mechanism
R01$13,663,691 · 3
U01$2,415,701 · 1
T32$2,205,479 · 1
U54$812,397 · 1
R21$674,726 · 2
R25$492,752 · 1
Top collaborators
- Gerard C Blobe2 shared
- Johnna M Frierson2 shared
- Simon G Gregory1 shared
Most similar at Duke University
Same institution · by research overlap
- Emmanuela Bonglack$52,484
- Michael Barry Kastan$65,974,699
- Simon G Gregory$4,851,317
Others in their field
Top investigators on “Viral”
- Lawrence Corey · Fred Hutchinson Cancer Center$466,994,927
- David Heimbrook · Leidos Biomedical Research, Inc.$366,090,791
- Daniel R Kuritzkes · Brigham And Women'S Hospital$267,074,199
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$252,763,614
- Judith S. Currier · University Of California Los Angeles$185,434,785
- Constance Ann Benson · University Of California, San Diego$165,517,633
Research focus
ViralImmuneHuman Herpesvirus 4VirusB-LymphocytesInfectionMolecularCellsMediatingGene ExpressionAdultProgramsIn VitroEpstein-Barr Virus InfectionsEpstein-Barr Virus LatencyLymphomaHerpesviridaePathogenesisIn VivoB Cell ProliferationGenesLymphoblastoid Cell LineS LymphomaBase
Grant awards (52)
Bridging cell and organism scales to model viral, cell, and microenvironmental determinants of infection outcome$812,397
U54 · FY2025 · AI · contact PI
Defining and exploiting EBV-infected cell heterogeneity in non-Hodgkin lymphomas$562,627
U01 · FY2025 · CA · contact PI
Host pathways regulating Epstein-Barr virus-mediated B cell growth transformation$486,657
R01 · FY2025 · CA · contact PI
Defining the Mechanisms of Epstein-Barr Virus Persistence and Recurrence$467,077
R01 · FY2025 · DE · contact PI
Defining Epstein-Barr virus reservoirs and EBV-regulated gene expression in multiple sclerosis$237,476
R21 · FY2025 · NS · contact PI
Defining and exploiting EBV-infected cell heterogeneity in non-Hodgkin lymphomas$746,527
U01 · FY2024 · CA · contact PI
Host pathways regulating Epstein-Barr virus-mediated B cell growth transformation$462,575
R01 · FY2024 · CA · contact PI
Defining the Mechanisms of Epstein-Barr Virus Persistence and Recurrence$457,736
R01 · FY2024 · DE · contact PI
Dissecting the role of EBV and P. falciparum in endemic Burkitt lymphoma pathogenesis$635,246
R01 · FY2023 · CA · contact PI
Defining and exploiting EBV-infected cell heterogeneity in non-Hodgkin lymphomas$555,946
U01 · FY2023 · CA · contact PI
Defining the Mechanisms of Epstein-Barr Virus Persistence and Recurrence$467,077
R01 · FY2023 · DE · contact PI
Host pathways regulating Epstein-Barr virus-mediated B cell growth transformation$456,312
R01 · FY2023 · CA · contact PI
Viral Oncology Training Grant$442,458
T32 · FY2023 · CA · contact PI
Duke Preparing Research Scholars in Biomedical Sciences- Post-Baccalaureate Research Education Program$246,376
R25 · FY2023 · GM
Dissecting the role of EBV and P. falciparum in endemic Burkitt lymphoma pathogenesis$640,406
R01 · FY2022 · CA · contact PI
Defining and exploiting EBV-infected cell heterogeneity in non-Hodgkin lymphomas$550,601
U01 · FY2022 · CA · contact PI
Viral Oncology Training Grant$467,606
T32 · FY2022 · CA · contact PI
Defining the Mechanisms of Epstein-Barr Virus Persistence and Recurrence$462,406
R01 · FY2022 · DE · contact PI
Host pathways regulating Epstein-Barr virus-mediated B cell growth transformation$439,114
R01 · FY2022 · CA · contact PI
Duke Preparing Research Scholars in Biomedical Sciences- Post-Baccalaureate Research Education Program$246,376
R25 · FY2022 · GM
Dissecting the role of EBV and P. falciparum in endemic Burkitt lymphoma pathogenesis$648,210
R01 · FY2021 · CA · contact PI
Host pathways regulating Epstein-Barr virus-mediated B cell growth transformation$494,354
R01 · FY2021 · CA · contact PI
Defining the Mechanisms of Epstein-Barr Virus Persistence and Recurrence$467,077
R01 · FY2021 · DE · contact PI
Viral Oncology Training Grant$450,166
T32 · FY2021 · CA · contact PI
Dissecting the role of EBV and P. falciparum in endemic Burkitt lymphoma pathogenesis$653,475
R01 · FY2020 · CA · contact PI
Targeting Apoptosis and Immune Control of Epstein-Barr Virus Infected Tonsillar B Cells$437,944
R01 · FY2020 · DE · contact PI
Viral Oncology Training Grant$430,999
T32 · FY2020 · CA · contact PI
Host pathways regulating Epstein-Barr virus-mediated B cell growth transformation$371,732
R01 · FY2020 · CA · contact PI
Dissecting the role of EBV and P. falciparum in endemic Burkitt lymphoma pathogenesis$673,494
R01 · FY2019 · CA · contact PI
Targeting Apoptosis and Immune Control of Epstein-Barr Virus Infected Tonsillar B Cells$437,944
R01 · FY2019 · DE · contact PI
Viral Oncology Training Grant$414,250
T32 · FY2019 · CA · contact PI
Host pathways regulating Epstein-Barr virus-mediated B cell growth transformation$360,580
R01 · FY2019 · CA · contact PI
AIDS-associated Opportunistic Infections & Cancers (AOIC) SWG$14,190
P30 · FY2019 · AI · contact PI
Targeting Apoptosis and Immune Control of Epstein-Barr Virus Infected Tonsillar B Cells$437,944
R01 · FY2018 · DE · contact PI
Host pathways regulating Epstein-Barr virus-mediated B cell growth transformation$371,732
R01 · FY2018 · CA · contact PI
AIDS-associated Opportunistic Infections & Cancers (AOIC) SWG$6
P30 · FY2018 · AI · contact PI
Targeting Apoptosis and Immune Control of Epstein-Barr Virus Infected Tonsillar B Cells$437,944
R01 · FY2017 · DE · contact PI
Host pathways regulating Epstein-Barr virus-mediated B cell growth transformation$371,732
R01 · FY2017 · CA · contact PI
Structural Studies of EBV Nuclear Proteins and Host Factors Important for Establishing Latency$198,750
R21 · FY2017 · AI · contact PI
AIDS-associated Opportunistic Infections & Cancers (AOIC) SWG$1
P30 · FY2017 · AI · contact PI
Targeting Apoptosis and Immune Control of Epstein-Barr Virus Infected Tonsillar B Cells$426,328
R01 · FY2016 · DE · contact PI
Host pathways regulating Epstein-Barr virus-mediated B cell growth transformation$371,732
R01 · FY2016 · CA · contact PI
Structural Studies of EBV Nuclear Proteins and Host Factors Important for Establishing Latency$238,500
R21 · FY2016 · AI · contact PI
AIDS-associated Opportunistic Infections & Cancers (AOIC) SWG$13,693
P30 · FY2016 · AI · contact PI
Host pathways regulating Epstein-Barr virus-mediated B cell growth transformation$325,775
R01 · FY2015 · CA · contact PI
Host pathways regulating Epstein-Barr virus-mediated B cell growth transformation$66,880
R01 · FY2015 · CA · contact PI
AIDS-associated Opportunistic Infections & Cancers (AOIC) SWG$10,987
P30 · FY2015 · AI · contact PI
Host pathways regulating Epstein-Barr virus-mediated B cell growth transformation$316,002
R01 · FY2014 · CA · contact PI
Host pathways regulating Epstein-Barr virus-mediated B cell growth transformation$60,427
R01 · FY2014 · CA · contact PI
Host pathways regulating Epstein-Barr virus-mediated B cell growth transformation$306,229
R01 · FY2013 · CA · contact PI
Host pathways regulating Epstein-Barr virus-mediated B cell growth transformation$325,775
R01 · FY2012 · CA · contact PI
Host pathways regulating Epstein-Barr virus-mediated B cell growth transformation$325,775
R01 · FY2011 · CA · contact PI